HCID 178452080, compound → HCID 178518511, compound

HRID 2036945Notes

Reaction equation

HRID 2036945 reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([NH:8][C:9]2[CH:14]=[C:13]([NH:15][CH:16]3[CH2:21][CH2:20][N:19](C(OC(C)(C)C)=O)[CH2:18][CH2:17]3)[N:12]3[N:29]=[CH:30][C:31]([CH:32]=[C:33]4[C:37](=[O:38])[NH:36][C:35](=[O:39])[NH:34]4)=[C:11]3[N:10]=2)[CH:5]=[CH:6][CH:7]=1>C(O)(C(F)(F)F)=O.C(Cl)Cl>[Cl:1][C:2]1[CH:3]=[C:4]([NH:8][C:9]2[CH:14]=[C:13]([NH:15][CH:16]3[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]3)[N:12]3[N:29]=[CH:30][C:31]([CH:32]=[C:33]4[NH:34][C:35](=[O:39])[NH:36][C:37]4=[O:38])=[C:11]3[N:10]=2)[CH:5]=[CH:6][CH:7]=1

Participants

3

Procedure

Tert-butyl 4-(5-(3-chlorophenylamino)-3-((2,5-dioxoimidazolidin-4-ylidene)methyl)pyrazolo[1,5-a]pyrimidin-7-ylamino)piperidine-1-carboxylate (640 mg, 1.2 mmol) was dissolved in 10 mL of TFA/DCM (1:1) and stirred at room temperature for 1 hour then quenched by addition to ice cold 6N NaOH. The mixture was diluted with water then the aqueous layer was decanted. The organic layer was diluted with hexanes and filtered. The product, 5-((5-(3-chlorophenylamino)-7-(piperidin-4-ylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methylene)imidazolidine-2,4-dione, was collected as a solid in quantitative yield. LCMS (M+1=453)

Workup

  1. customthen quenched by addition to ice cold 6N NaOH
  2. additionThe mixture was diluted with water
  3. customthe aqueous layer was decanted
  4. additionThe organic layer was diluted with hexanes
  5. filtrationfiltered
  6. customThe product, 5-((5-(3-chlorophenylamino)-7-(piperidin-4-ylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methylene)imidazolidine-2,4-dione, was collected as a solid in quantitative yield

Sources & evidence

ORD record
ord-fd8d81a44729423ba4f038a72ec1674f
Source dataset
uspto-grants-2013_11
Patent number
US08575177B2

Reaction notes

Loading…